Eli Lilly Cuts Q4 Revenue Guidance, Expects Around $5.5 Billion Sales From Weight Loss/Diabetes Drugs, Stock Tanks - Yahoo Finance
Eli Lilly Cuts Q4 Revenue Guidance, Expects Around $5.5 Billion Sales From Weight Loss/Diabetes Drugs, Stock Tanks Yahoo FinanceEli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand CNBCEli Lilly forecasts weaker Q4 sales of weight-loss drug, Mounjaro than expected Yahoo FinanceEli Lilly’s stock falls as weight-loss drug sales disappoint MarketWatchLilly 2024 Sales Miss Estimate as Weight-Loss Drugs Slow Bloomberg
- Eli Lilly Cuts Q4 Revenue Guidance, Expects Around $5.5 Billion Sales From Weight Loss/Diabetes Drugs, Stock Tanks Yahoo Finance
- Eli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand CNBC
- Eli Lilly forecasts weaker Q4 sales of weight-loss drug, Mounjaro than expected Yahoo Finance
- Eli Lilly’s stock falls as weight-loss drug sales disappoint MarketWatch
- Lilly 2024 Sales Miss Estimate as Weight-Loss Drugs Slow Bloomberg
What's Your Reaction?